Trump’s pick for HHS deputy secretary supports review of abortion-pill risk
The Washington Times
By Valerie Richardson
President Trump’s choice for a deputy secretary post said he “strongly supports” conducting a safety review of mifepristone, the abortion pill found in a recent study to be more dangerous than its label suggests.
James O’Neill, the president’s pick for the No. 2 position at the Department of Health and Human Services, addressed the safety issue during his Thursday confirmation hearing while being questioned by Sen. Josh Hawley, Missouri Republican.
Mr. Hawley cited the Ethics and Public Policy Center’s study of insurance data on 865,727 cases, which found that 10.93% of pregnant women who take the drug get sick within 45 days, a figure 22 times higher than reflected on the warning label.